Analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research report issued on Friday. The brokerage set a “hold” rating on the stock.
China Pharma Price Performance
CPHI opened at $0.21 on Friday. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. The firm has a fifty day moving average price of $0.20 and a 200 day moving average price of $0.22. China Pharma has a 1 year low of $0.13 and a 1 year high of $0.60.
About China Pharma
See Also
- Five stocks we like better than China Pharma
- The Most Important Warren Buffett Stock for Investors: His Own
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- What Do S&P 500 Stocks Tell Investors About the Market?
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- What is the FTSE 100 index?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
